Exchange: NASDAQ·Updated 07:45 AM EDT
BDSX logo

BDSX Biodesix Inc

$25.82
$0.525
(1.99%)
Pre-Market
Prev Close $26.35
Reported EarningsAug 5
Mkt Cap$277.97M
Vol50.00

About BDSX

Biodesix, Inc. operates as a diagnostic solutions company. It engages in providing blood-based diagnostic tests and development services. The firm offers five diagnostic tests, including Nodify CDT, Nodify XL2, GeneStrat ddPCR, GeneStrat NGS, and VeriStrat. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
45

Neutral Sentiment

How do you feel about BDSX?

Advertisement|Remove ads.